COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

The Efficacy and Safety of rhTNK-tPA in Comparison With Alteplase(Rt-PA) as Fibrinolytic Therapy of Acute STEMI

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02835534
Recruitment Status : Unknown
Verified July 2016 by Guangzhou Recomgen Biotech Co., Ltd..
Recruitment status was:  Active, not recruiting
First Posted : July 18, 2016
Last Update Posted : July 18, 2016
Chinese Academy of Medical Sciences, Fuwai Hospital
Peking University
Information provided by (Responsible Party):
Guangzhou Recomgen Biotech Co., Ltd.